Primary record
Benzamide,N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-,rel-
- 库存
- 7,870 克
- 纯度
- 98.4 %
- CAS
- 1035270-39-3
化合物标识与属性
- CAS
- 1035270-39-3
- PubChem CID
- 51039095
- SMILES
- C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC
- Canonical SMILES
- COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@@H](C)N[C@@H](C)C4)cc3)n[nH]2)cc(OC)c1
名称与同义词
- AZD4547
- AZD-4547
- 1035270-39-3
- fexagratinib
- 2-Butyryldimedone
- fexagratinib [INN]
- AZD 4547
- Tube729
- Fexagratinib (Standard)
- Fexagratinib [WHO-DD]
- RefChem:560460
- 2167OG1EKJ
- UNII-2167OG1EKJ
- ABSK091
- AZD4547, Free Base
- D0NU0U
- ABSK-091
- QCR-89
- MFCD22580423
- SCHEMBL63884
- ADSK091
- CHEBI:63453
- DTXSID80145887
- C26H33N5O3
- GTPL7707
- orb1307009
- CHEMBL3348846
- DTXCID9068378
- SCHEMBL15250892
- SCHEMBL29479542
- VRQMAABPASPXMW-HDICACEKSA-N
- GLXC-90036
- KB-74810
- AMY16612
- AOB87745
- AZD4547?
- EX-A1578
- 2240AH
- ABP000893
- HY-13330R
- NSC764239
- NSC765338
- NSC799346
- s2801
- ZINC95616598
- AKOS024464898
- AZD4547/AZD-4547/
- ACN-037519
- BCP9000364
- CCG-269382
- CS-0971
- DB12247
- EBC-219083
- FA64951
- NSC-764239
- NSC-765338
- NSC-799346
- RL00169
- SDCCGSBI-0654475.P001
- NCGC00346713-01
- NCGC00346713-05
- NCGC00346713-10
- AC-28442
- AS-17054
- BC261861
- CID:51039095
- DA-50853
- HY-13330
- N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide
- SID:405021222
- A8350
- NS00073078
- SW219341-1
- J3.264.181D
- A11075
- Q-4033
- rel-N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-3,5-dimethylpiperazin-1-yl)benzamide
- A852143
- C572463
- N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide
- BRD-K28392481-001-05-1
- Q27074746
- N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide
- B0084-456576
- N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-rel-3,5-dimethylpiperazin-1-yl)benzamide
- N-{3-[2-(3,5-Dimethoxyphenyl)ethyl]-1h-Pyrazol-5-Yl}-4-[(3r,5s)-3,5-Dimethylpiperazin-1-Yl]benzamide
- rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide
- AZD4547, 98%, a potent inhibitor of the FGFR family - 10MG 10mg
- N-(5-(2-(3,5-DIMETHOXYPHENYL)ETHYL)-1H-PYRAZOL-3-YL)-4-((3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL)BENZAMIDE
- N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]benzamide
- N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-(cis-3,5-dimethylpiperazin-1-yl)benzamide
- 17450-95-2
- 66T
- Benzamide,N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-,rel-
- N-(5-(2-(3,5-dimethoxyphenyl)ethyl)-2H-pyrazol-3-yl)-4-(3,5-diemthylpiperazin-1-yl)benzamide
- N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-3,5-dimethylpiperazin-1-yl)benzamide
- N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-3,5-dimethylpiperazin-1-yl)benzamide, rel-
- N-(5-(3,5-Dimethoxyphenethyl)-4H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide
- N-[3-(3,5-Dimethoxyphenethyl)-1H-pyrazole-5-yl]-4-(3alpha,5alpha-dimethyl-1-piperazinyl)benzamide
- N-[3-(3,5-Dimethoxyphenethyl)-1H-pyrazole-5-yl]-4-[(3S,5R)-3,5-dimethyl-1-piperazinyl]benzamide
- N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-Benzamide
- N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin -1-yl]benzamide
- N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide
- rel-N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide